BIO-key will present biometric solutions related to identity on booth 441 of the Connect: ID conference on October 5 and 6 and will participate in several sessions on the agenda


WALL, NJ, Oct 01, 2021 (GLOBE NEWSWIRE) – BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management (IAM) and Identity Biometrics solutions , announced today the company will be a sponsor and exhibitor at the Connect: ID Identity 2021 conference and exhibition, to be held at the Walter E. Washington Convention Center in Washington, DC from October 5-6. BIO-key will be available for question-and-answer sessions and live demonstrations of their cutting-edge identity-related biometric software and hardware solutions at booth 441. In addition, Michael DePasquale, President and CEO of BIO-key , and Jim Sullivan, senior vice president of strategy and compliance and the CLO, will be featured experts on several sessions on the agenda.

The Connect: ID conference will bring together industry leaders and pioneers to discuss current government policies and provide insight into the future of identity. The event is a world-class identity conference and exhibition, showcasing practical implementations of trusted identity solutions and highlighting how disruptive technologies and political decisions are driving much needed change. The theme of this year’s event is Identity: Reinvented.

Attendees are invited to stop by booth 441 to learn more about BIO-key’s unique range of IAM solutions, including Biometric Civil Identification, Multi-Factor Authentication (MFA) and Single Sign-On (SSO) for the identities of employees, customers and suppliers, who have their proprietary identity-linked biometrics (IBB). IBB fills important user experience gaps in traditional MFA solutions by positively and conveniently identifying users, not just their device, in password-less, phone-less, and token-free use cases, including for remote workers and in situations such as retail, healthcare, manufacturing, and call centers, where users move between shared workstations or may be distracted by phones or looking for ‘a hardware token to log in. BIO-key will showcase IBB via multiple supported modes including their new MobileAuthMT with PalmPositiveMT mobile application that uses a scan of the phone’s camera palm to positively authenticate users.

BIO-key will also showcase a full line of hardware peripherals, including:

  • Fingerprint readers: BIO-key offers a variety of fingerprint scanners, including a range of Microsoft qualified Windows Hello USB scanners that can be used directly with Windows Hello and Windows Hello for Business or in conjunction with Identity Biometrics. BIO-key:

    • Mobile ID FAP 50 and Pocket10 â„¢ Live Scan (10-Print) certified by the FBI for verification capture in 4-4-2 format.

    • PIV-Pro FIPS-201 compatible scanner

    • The all new EcoID â„¢ II

    • SidePass Compact USB-A or -C Scanner

    • SideSwipe Compact USB-A Scanner

  • FIDO security keys: FIDO BIO-key is a range of affordable FIDO2 security keys, offering USB-A, USB-C, NFC and iOS Lightning compatibility as well as FIPS 140-2 certified options with biometric verification on the device .

  • All-in-one point of sale terminal: BIO-key MobilePOS Pro is a portable all-in-one smart point of sale machine, with an integrated FBI certified fingerprint module for biometric identification and verification. Developed for the payments industry, BIO-key MobilePOS Pro is able to meet various transaction goals, but is also suitable for various usage scenarios, such as microfinance, SIM registration, inventory management, etc.

Members of the BIO-key management team will be featured as speakers on the conference agenda as experts in the fields of identity and biometrics.

The conference is sponsored by one of the leading biometrics advocacy organizations, the International Biometrics and Identification Industry Association (IBIA). Michael DePasquale, CEO of BIO-key, is the organization’s vice-president and board member and will attend the main IBIA plenary session on October 6 at 1:20 p.m. In this session , “Challenges and Opportunities in Biometrics and Identity Management – An IBIA Perspective”, he will explain how organizations can include biometric solutions in their identity management strategy.

Jim Sullivan, Senior Vice President of Strategy and Compliance and General Counsel of BIO-key, will attend several sessions, including a presentation on October 5 at 11:20 am in the seminar theater on “You Will Know Biometrics arrived when… ”to discuss the indicators that biometrics has become a mainstream authentication option, and at 2:00 pm to host a panel discussion on“ Fiction, FUD and Friction – the demonization of server biometrics was it a calculated attack? On October 6, Jim will then join an expert panel at 11:05 am to discuss “Cutting Edge IAM”.

“We welcome this opportunity to participate in Connect: ID,” said Michael DePasquale. “We are delighted to attend and sponsor this event at such a critical time when we need to reinvent identity and come together to discuss and understand how we can use technology to confirm human identity in our physical and digital worlds.

For more information on the Connect: ID 2021 conference, please visit the conference website. To learn more about BIO-key’s IAM and identity-related biometric solutions, please visit the BIO-key website.

About BIO-key International, Inc. (
BIO-key has more than two decades of expertise in providing authentication technologies for thousands of organizations and millions of users and is revolutionizing authentication with multi-factor identity and access management (IAM) solutions and biometrics, including its PortalGuard IAM solution, which provides secure access to high-value devices, information, applications and transactions. BIO-key’s patented software and hardware solutions with industry-leading biometric capabilities enable large-scale on-premises and Identity-as-a-Service (IDaaS) solutions as well as customized enterprise and cloud solutions.

About CyberSecurity Breakthrough
Part of Technological breakthrough, one of the leading market intelligence and recognition platforms for global technology innovation and leadership, the CyberSecurity Breakthrough Awards program is dedicated to honoring excellence in technology companies, products and people. information security and cybersecurity. The CyberSecurity Breakthrough Awards provide a platform for public recognition around the achievements of companies and breakthrough information security products in categories such as cloud security, threat detection, risk management, prevention from fraud, mobile security, web and email security, UTM, firewalls and more. For more information visit

BIO-key Safe Harbor Declaration
All statements in this press release other than statements of historical fact are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate”, “plan”, “intend”, “expect”, “anticipate”, “believe” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on the beliefs of management, as well as assumptions made by management and information currently available to management in accordance with the “safe harbor” provisions of the Law. These statements do not constitute guarantees of performance or future events and are subject to risks and uncertainties that could cause actual results to differ materially from those included or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, our history of loss and limited income; our ability to raise additional capital; our ability to protect our intellectual property; changes in trading conditions; changes in our sales strategy and product development plans; changes in the market; ongoing services from our management team; security failures; competition in the biometric technology industry; market acceptance of biometric products in general and our products under development; our ability to execute and deliver contracts in Africa; our ability to grow in Asia, Africa and other foreign markets; the duration and severity of the current COVID-19 coronavirus pandemic and its effect on our business operations, sales cycles, people and the geographic markets in which we operate; delays in product development and statements of assumption underlying all of the above as well as other factors set out under the heading see “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of writing. forward-looking statements, whether as a result of new information, future events or otherwise. In addition, there may be other factors of which the Company is not currently aware that may affect the matters addressed in the forward-looking statements and may also cause actual results to differ in particular, the consequences of the outbreak. of coronavirus on economic conditions and industry in general, as well as on the financial position and operations Our Company’s results, in particular, have been significant, are changing rapidly and cannot be predicted.

Get involved with BIO-key:
Facebook – Company:
LinkedIn – Company:
Twitter – Company: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

BIO-key media contact:
Erin knapp
Communication of the case
[email protected]

Investor contacts:
William Jones, David Collins
IR Catalyst
[email protected]


Leave A Reply